CSL - Sales Revenues

Stock Price
134.62
Daily Change
-3.38 -2.45%
Monthly
-12.17%
Yearly
-47.27%
Q1 Forecast
138.07

CSL reported $8.33B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
CSL USD 8.33B 4.79B Dec/2025
Curis USD 2.55M 460K Jun/2024
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
Sangamo BioSciences USD 356K 125K Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024